Article

Join Our World Cancer Day Tweet Chat

Author(s):

CURE staff

World Cancer Day is approaching. Join us on Monday's #CureConnect tweet chat to discuss how cancer has impacted your life.

Sunday, Feb. 4 is World Cancer Day, and we want to hear from fellow patients, survivors, caregivers and advocates about how cancer has impacted their lives.

Join our #CureConnect tweet chat on Monday, Feb. 5, at 1 p.m., EST, to discuss World Cancer Day. This year’s theme is, “We can. I can,” so we’ll be talking about how individuals and groups alike can raise awareness and further education about the disease. We’ll also discuss how patients, survivors and caregivers can be their own advocate — whether it be with health care teams, insurance companies or on Capitol Hill.

In February 2000, the Paris Charter adopted the World Summit Against Cancer for the New Millennium in Paris, with the goal of promoting research behind a cure and prevention, as well as offering services to patients. And so, World Cancer Day, which is coordinated by the Switzerland-based Union for International Cancer Control, was born.

We’d love to hear from you!

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Anne M. Reb is a nurse practitioner with City of Hope.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Kate, Princess of Wales, ‘Got So Attached’ to Her Port During Cancer Treatment
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Stephanie Alice Baker
Related Content
From left: JILL REESE, M.S., APRN, AGCNS-BC, OCN, and SUSIE MALONEY, M.S., APRN, AOCN, AOCNS
April 27th 2025

Healer, Mentor and Leader

Susie Maloney, M.S., APRN, AOCN, AOCNS
Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
From left: KATHLEEN COUGHLIN, M.S.N., ANP-BC, BMTCN, and ANTONIA MALONEY, B.S.N., RN, OCN
April 24th 2025

The Fearless Patient Advocate

Antonia Maloney, BSN, RN, OSN
Kathleen Coughlin, although small in stature, is often referred to as the “Bulldozer.”
Megan Piotrowicz
December 22nd 2022

Childhood Cancer Survivor Pays It Forward at the Same Hospital She Received Treatment

Sailaja Darisipudi Darlene Dobkowski, MA
A childhood cancer survivor now works raising funds for Children’s Hospital of Philadelphia, the same hospital where she received treatment for Ewing sarcoma at 12 years old.
The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation: © stock.adobe.com.
April 19th 2025

Illuminating Compassion in Cancer Care

Mike Hennessy Jr.
The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation.
Illustration of giant cell.
April 17th 2025

Emactuzumab Gets Fast Track Designation in Tenosynovial Giant Cell Tumors

Ryan Scott
Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery.